What is HALEOSLABS (HALEOSLABS) share price today?

HALEOSLABS (HALEOSLABS) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/HALEOSLABS for the latest live price, technical analysis, and AI-powered insights.

How to analyse HALEOSLABS stock?

VestAI provides comprehensive HALEOSLABS stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is HALEOSLABS in?

HALEOSLABS (HALEOSLABS) is in the Unknown sector, Pharmaceuticals industry on the NSE.

HALEOSLABS

Q: What is HALEOSLABS's Orion Score?

HALEOSLABS has an Orion Score of 41/100 (Caution) — a fundamentals-based quality & risk score. HALEOSLABS scores 41/100 (Caution) on the Orion Score — weak business quality (45), poor growth (16), weak balance-sheet safety (40) and fair valuation (60). A fundamentals-based quality & risk score, not a buy/sell recommendation.

NSE

₹1,619.00

+31.70 (+2.00%)

Updated 06:46 am IST

52W Low · ₹1,196.7052W High · ₹1,759.90

Near 52W High

Market Cap

₹418.45L Cr

Volume

372

Prev Close

₹1,587.30

ISIN

INE320X01016

Orion Score

Fundamentals-based quality & risk · not a recommendation

41/100

Caution

HALEOSLABS scores 41/100 (Caution) on the Orion Score — weak business quality (45), poor growth (16), weak balance-sheet safety (40) and fair valuation (60). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.2× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 3/9Altman Z Safe(4.99)Beneish M Clean(-2.80)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

31/100

Weak

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.31x — lean balance sheet

QUALITY

Average

ROCE 12.2% — decent returns

MOMENTUM

Bullish

RSI 56.1 — strong momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q3 FY2026

P/E Ratio: 24.16
ROCE: 12.15%
ROE (1Y): 10.80%
D/E Ratio: 0.31x
OPM: 10.70%
TTM EPS: ₹57.30
Dividend Yield: 9.00%
Qtrly Sales: ₹94.78 Cr
Qtrly Profit: ₹6.62 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q3 2026	₹94.78	₹6.62	10.7%	₹21.89
Q2 2026	₹81.37	₹6.1	11.9%	₹20.19
Q1 2026	₹82.5	₹4.16	9.6%	₹13.75
Q4 2025	₹81.17	₹2.97	4.6%	—
Q3 2025	₹84.6	₹5.47	10.6%	₹18.08

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2025	₹336.78	₹20.11	₹49.64	8.9%
FY 2024	₹299.56	₹9.09	₹34.74	5.4%
FY 2023	₹312.55	₹11.46	₹33.81	5.8%
FY 2022	₹347.3	₹25.32	₹48.44	7.1%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹389.99	₹391.33	₹394.89	₹356.75
Equity	₹196.56	₹176.81	₹168.61	₹152.23
Total Debt	₹86.41	₹100.72	₹100.49	₹79.6
Cash	₹0.5	₹0.57	₹1.28	₹0.99
Net Debt	₹83.51	₹97.14	₹97.36	₹76.28
Working Capital	₹8.51	₹10.71	₹25.55	₹20.58

Shareholding Pattern

Q1 FY2027

Promoter

74.97%

FII

DII

Public

25.03%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	74.97% ↑	0%	0% ↓	25.03% ↓
Q3 FY2026	71.79% ↑	0%	0.29% ↑	27.91% ↓
Q2 FY2026	71.4%	0% ↓	0.03% ↑	28.57% ↑
Q1 FY2026	71.4%	0.03% ↑	0%	28.56% ↓
Q4 FY2025	71.4%	0%	0%	28.6% ↑
Q3 FY2025	71.4%	0% ↓	0%	28.59% ↑
Q2 FY2025	71.4%	0.02% ↑	0%	28.57% ↓
Q1 FY2025	71.4%	0.01%	0%	28.59%

Corporate Actions

No recent corporate actions

Analyse HALEOSLABS with Orion AI

Ask: "Is HALEOSLABS stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About HALEOSLABS (HALEOSLABS) Stock

HALEOSLABS is listed on the NSE under the Unknown sector, Pharmaceuticals industry. ISIN: INE320X01016. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.